Is NXP 3P the Same as Reta?

In most cases, yes — NXP 3P is the same as reta in practice, because "NXP 3P" is a vendor code name for retatrutide, the investigational triple-agonist peptide commonly shortened to "reta." The two labels point to one molecule, not two different compounds. The differences come from catalog naming and marketing, not from chemistry.

Where the Names NXP 3P, GPL3, and FG3 R Come From

Retatrutide is still an investigational drug, so it has no approved consumer brand name. In the gray-market research peptide space, that gap gets filled with internal catalog codes. Sellers rotate these labels to sidestep trademark issues, search filters, and payment processors.

That is why the same vial may appear as NXP 3P on one site, GPL3 on another, and FG3 R on a third. Someone typing gpl3 reta into a search bar or asking is fg3 r reta is chasing the same compound under a different code. This naming pattern is not unique to this peptide.

Similar confusion runs across the whole category. People ask is bremelanotide the same as pt 141 and is cjc 1295 the same as ipamorelin for exactly the same reason: one molecule, several labels, and very little standardization.

What Retatrutide Actually Is

Retatrutide is a synthetic peptide that acts as an agonist at three receptors: GIP, GLP-1, and glucagon. That triple mechanism is what separates it from older GLP-1 drugs that target one or two pathways.

It is not approved by the FDA for any use. The human data available today comes from sponsor-run clinical trials, and the compound sold online is labeled as a research chemical only. Questions like is semaglutide the same as ozempic or wegovy come up in the same conversations, but the answer there is different: semaglutide is the active ingredient inside those brand-name products.

NXP 3P vs GPL3 vs FG3 R vs Retatrutide

Label	What it typically refers to	Where you see it	What the label proves
Retatrutide	The actual compound name	Clinical literature, patents, regulatory filings	Identifies the molecule, not a specific vial
RETA	Shorthand for retatrutide	Forums, research discussions	Nothing about purity or source
NXP 3P	Vendor code for retatrutide	Online peptide catalogs	Nothing about identity or quality
GPL3	Vendor code for retatrutide	Online peptide catalogs	Nothing about identity or quality
FG3 R	Vendor code for retatrutide	Online peptide catalogs	Nothing about identity or quality

Across every row, the expected identity is the same peptide. What changes is how much verified information the label carries, and vendor codes carry almost none.

What a Code Name Does Not Tell You

• Purity. Codes are not tied to any published or enforceable specification.
• Identity. Nothing on the label proves the vial contains retatrutide at all.
• Sterility and storage. There are no guarantees about how the material was made, filtered, or shipped.
• Source. Unrelated sellers can use the same code for entirely different products.
• Dose accuracy. A code does not standardize how much compound is in each vial.

A certificate of analysis is only as trustworthy as the lab that issued it. Independent third-party HPLC and mass spectrometry results are the closest thing to real verification available to a buyer.

How to Compare Two Labels Before Assuming They Match

1. Check the molecular formula and molecular weight against published literature.
2. Look for a CAS number, sequence, or other unique identifier.
3. Compare third-party test results rather than marketing copy.
4. Confirm the stated form — lyophilized powder versus pre-mixed liquid.
5. Ask whether the seller will name the testing laboratory publicly.

If two listings share a formula, a molecular weight, and independent test data, they almost certainly describe the same peptide. If a listing shows only a code and a price, nothing is confirmed.

Reconstitution, Handling, and Safety Questions

Research peptides usually ship as lyophilized powder and require reconstitution before use. Buyers often ask is reconstitution solution the same as bac water or is bac water the same as saline, and the answer is no in both cases — these liquids differ in composition, preservatives, and intended use.

None of that makes an unapproved compound safe to self-administer. Retatrutide has not been reviewed for human use, gray-market dosing is unstandardized, and triple agonists have been associated with significant gastrointestinal effects, heart rate changes, and other serious reactions in trial settings.

Anyone considering a GLP-1 class medication should talk with a licensed healthcare professional about approved options rather than relying on vendor code names and forum posts.

Quick Answer Recap

NXP 3P, GPL3, and FG3 R are code names that generally point to retatrutide. They are not separate drugs, and they are not evidence of quality. Sellers who use codes should be held to a higher standard of documentation, not a lower one.

COMMON QUESTIONS

Frequently Asked Questions

Is NXP 3P the same as retatrutide?

In most cases, yes. NXP 3P is a vendor code name that suppliers use for retatrutide, the investigational triple-agonist peptide also shortened to reta. Because these code names are not regulated, you cannot confirm identity without independent third-party testing.

Why do peptide sellers use code names like GPL3 and FG3 R?

Sellers use code names to avoid trademark issues, slip past search filters and payment processors, and make comparison shopping harder. The codes also let suppliers change products without changing the listing language. A code name carries no verified chemical information on its own.

Is retatrutide FDA-approved or legal to buy?

No. Retatrutide is an investigational drug and is not FDA-approved for any human use. It is sold online as a research chemical, which is not the same as being legal for personal consumption, and using it carries unknown health risks that should be discussed with a healthcare professional.